Advanced Micro Devices, Inc. · AMD · FY2026 Q2 · Calendar Q3 2026
AMD pairs record Q2 revenue with an ambitious AI infrastructure ramp
The supplied analysis supports the view that resilient AI-compute demand and accelerating product adoption can sustain AMD's growth trajectory over the next year. The countercase is that supply constraints, memory costs, GPU mix, and execution could limit margin expansion or delay the ramp.
Earnings scorecard
Reported versus consensusMarket reaction
event-close to next-session closeAsk FN2 about AMD FY2026 Q2
Transcript, numbers and history already loadedFree account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
Compared with the prior quarter, AMD's narrative moved from strong AI-driven demand and planned Helios production toward reported execution: record revenue, data center at 58% of total, Venice in production, and Helios and MI450 ahead of forecast. Management also introduced ROCm.ai and highlighted new partnerships, while the focus of investor concern shifted more heavily to ramp execution, mix, costs, and monetization.
Guidance delta
Management raised the outlook: Q3 revenue is projected around $13 billion, up 41% year over year, with continued margin expansion and data-center revenue expected to more than double in 2027.
Key takeaways
- Q2 revenue reached a record $11.5 billion, up 50% year over year, with data center at 58% of total revenue.
- EPYC and Instinct demand remained strong, while Venice entered production and Helios and MI450 were described as ahead of forecast.
- The next phase depends on scaling new platforms, supply capacity, margins, and AI infrastructure execution.
Management priorities
- Scale EPYC Venice and the broader OEM platform portfolio.
- Ramp MI450 and the Helios rack-scale AI platform, with the next-generation MI500 and Verano platform planned for 2027.
- Expand ROCm.ai, developer support, AI-PC products, and partnerships with Anthropic, Microsoft, OpenAI, Meta, and Cerebras.
Follow AMD with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Analyst 52W Price Targets
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Sep 22, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Raymond James | Strong Buy | Outperform | Upgrade | Aug 25, 2026 |
| BMO Capital | Outperform | Outperform | Maintain | Aug 21, 2026 |
| Rosenblatt | Buy | Buy | Maintain | Aug 6, 2026 |
| Argus Research | Buy | Buy | Maintain | Aug 6, 2026 |
| Wells Fargo | Overweight | Overweight | Maintain | Aug 5, 2026 |
| Wedbush | Outperform | Outperform | Maintain | Aug 5, 2026 |
| Truist Securities | Buy | Buy | Maintain | Aug 5, 2026 |
| RBC Capital | Sector Perform | Sector Perform | Maintain | Aug 5, 2026 |
| Northland Capital Markets | Market Perform | Market Perform | Maintain | Aug 5, 2026 |
| Morgan Stanley | Equal Weight | Equal Weight | Maintain | Aug 5, 2026 |
| Keybanc | Overweight | Overweight | Maintain | Aug 5, 2026 |
| JP Morgan | Neutral | Neutral | Maintain | Aug 5, 2026 |
| Evercore ISI Group | Outperform | Outperform | Maintain | Aug 5, 2026 |
| DA Davidson | Buy | Buy | Maintain | Aug 5, 2026 |
| Cantor Fitzgerald | Overweight | Overweight | Maintain | Aug 5, 2026 |
| Barclays | Overweight | Overweight | Maintain | Aug 5, 2026 |
| Susquehanna | Positive | Positive | Maintain | Jul 30, 2026 |
| Mizuho | Outperform | Outperform | Maintain | Jul 27, 2026 |
| UBS | Buy | Buy | Maintain | Jul 24, 2026 |
| Roth Capital | Buy | Buy | Maintain | Jul 24, 2026 |
| Jefferies | Buy | Buy | Maintain | Jul 24, 2026 |
| Benchmark | Buy | Buy | Maintain | Jul 23, 2026 |
| B of A Securities | Buy | Buy | Maintain | Jul 14, 2026 |
| TD Cowen | Buy | Buy | Maintain | Jul 13, 2026 |
| Stifel | Buy | Buy | Maintain | Jul 10, 2026 |
| Goldman Sachs | Buy | Buy | Maintain | Jul 6, 2026 |
| Bernstein | Outperform | Outperform | Maintain | Jun 17, 2026 |
| Citigroup | Buy | Neutral | Upgrade | Jun 12, 2026 |
| Melius Research | Buy | Buy | Maintain | May 18, 2026 |
| Daiwa Capital | Outperform | Buy | Maintain | May 13, 2026 |
| Seaport Global | Buy | Neutral | Upgrade | May 6, 2026 |
| Deutsche Bank | Hold | Hold | Maintain | May 6, 2026 |
| Baird | Outperform | Outperform | Maintain | May 6, 2026 |
| HSBC | Hold | Buy | Downgrade | May 4, 2026 |
| Piper Sandler | Overweight | Overweight | Maintain | Jan 26, 2026 |
| CICC | Outperform | Market Perform | Upgrade | Nov 7, 2025 |
| Wolfe Research | Outperform | Peer Perform | Upgrade | Oct 14, 2025 |
| Loop Capital | Buy | Buy | Maintain | May 7, 2025 |
| Roth MKM | Buy | Buy | Maintain | Oct 11, 2024 |
| DZ Bank | Hold | Buy | Downgrade | Mar 7, 2024 |
| New Street Research | Buy | Neutral | Upgrade | Jan 24, 2024 |
| Craig-Hallum | Buy | Buy | Maintain | Jun 14, 2023 |
| Credit Suisse | Outperform | Outperform | Maintain | Feb 1, 2023 |
| Cowen & Co. | Outperform | Outperform | Maintain | Oct 10, 2022 |
| KGI Securities | Outperform | Neutral | Upgrade | Aug 3, 2022 |
| Nomura | Buy | Buy | Maintain | Apr 29, 2020 |
| CFRA | Buy | Buy | Maintain | Apr 29, 2020 |
| Northland | Outperform | Market Perform | Upgrade | Mar 13, 2020 |
| Atlantic Equities | Overweight | Neutral | Upgrade | Mar 6, 2020 |
| Exane BNP Paribas | Neutral | Outperform | Downgrade | Jan 29, 2020 |
| Nomura Instinet | Buy | Buy | Maintain | Jan 2, 2020 |
| Piper Jaffray | Neutral | Neutral | Maintain | Aug 19, 2019 |
| Bank of America | Buy | Buy | Maintain | Apr 8, 2019 |
| Northland Securities | Market Perform | Outperform | Downgrade | Sep 27, 2018 |
| Stifel Nicolaus | Buy | Buy | Maintain | Sep 20, 2018 |
| Argus | Buy | Buy | Maintain | Sep 14, 2018 |
| Macquarie | Neutral | Underperform | Upgrade | Dec 18, 2017 |
| Longbow Research | Neutral | Neutral | Maintain | Jun 9, 2017 |
| MKM Partners | Buy | Buy | Maintain | Nov 22, 2016 |
| Oppenheimer | Perform | Underweight | Upgrade | Oct 17, 2016 |
| Canaccord Genuity | Hold | Hold | Maintain | Jun 16, 2016 |
| Ascendiant Capital | Hold | Buy | Downgrade | Apr 17, 2015 |
| Pacific Crest | Sector Perform | Underperform | Upgrade | Oct 17, 2014 |
| FBR Capital | Market Perform | Market Perform | Maintain | Oct 16, 2014 |
| Imperial Capital | Outperform | Outperform | Maintain | Oct 10, 2014 |
| Maxim Group | Market Perform | Market Perform | Maintain | Jan 23, 2013 |
| Williams Capital | Buy | Buy | Maintain | Oct 12, 2012 |
| Sterne Agee | Neutral | Neutral | Maintain | Oct 12, 2012 |
| Williams Financial | Buy | Buy | Maintain | Jul 10, 2012 |
Named analyst price targets
Upside is calculated against the persisted current price $623.77. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Piper Sandler | Analyst unavailable | $600 | $521.1 | -3.8% | Sep 9, 2026 |
| CLSA | Bhavtosh Vajpayee | $710 | $505.74 | +13.8% | Sep 9, 2026 |
| Raymond James | Simon Leopold | $641 | $456.74 | +2.8% | Aug 25, 2026 |
| BMO Capital | Analyst unavailable | $550 | $469.46 | -11.8% | Aug 20, 2026 |
| Argus Research | Analyst unavailable | $625 | $487.98 | +0.2% | Aug 6, 2026 |
| D.A. Davidson | Gil Luria | $550 | $486.59 | -11.8% | Aug 5, 2026 |
| Wells Fargo | Analyst unavailable | $700 | $518.58 | +12.2% | Aug 5, 2026 |
| Morgan Stanley | Joseph Moore | $465 | $518.58 | -25.5% | Aug 5, 2026 |
| Bernstein | Stacy Rasgon | $650 | $518.58 | +4.2% | Aug 5, 2026 |
| Jefferies | Blayne Curtis | $650 | $518.58 | +4.2% | Aug 5, 2026 |
| Truist Financial | William Stein | $594 | $518.58 | -4.8% | Aug 5, 2026 |
| KeyBanc | Analyst unavailable | $650 | $518.58 | +4.2% | Aug 5, 2026 |
| Mizuho Securities | Analyst unavailable | $625 | $486.98 | +0.2% | Jul 27, 2026 |
| Roth Capital | Suji Desilva | $650 | $539.69 | +4.2% | Jul 24, 2026 |
| Melius Research | Ben Reitzers | $660 | $539.69 | +5.8% | Jul 24, 2026 |
| Robert W. Baird | Tristan Gerra | $1,250 | $539.69 | +100.4% | Jul 24, 2026 |
| UBS | Timothy Arcuri | $730 | $539.69 | +17.0% | Jul 24, 2026 |
| Jefferies | Blayne Curtis | $640 | $539.69 | +2.6% | Jul 24, 2026 |
| UBS | Timothy Arcuri | $700 | $548.13 | +12.2% | Jul 15, 2026 |
| KeyBanc | Analyst unavailable | $725 | $534.39 | +16.2% | Jul 14, 2026 |
| Stifel Nicolaus | Analyst unavailable | $635 | $546.72 | +1.8% | Jul 10, 2026 |
| Goldman Sachs | Analyst unavailable | $640 | $517.82 | +2.6% | Jul 6, 2026 |
| Wells Fargo | Analyst unavailable | $615 | $539.49 | -1.4% | Jun 30, 2026 |
| Cantor Fitzgerald | Analyst unavailable | $700 | $521.58 | +12.2% | Jun 29, 2026 |
| UBS | Analyst unavailable | $670 | $519.85 | +7.4% | Jun 24, 2026 |
| Bernstein | Analyst unavailable | $600 | $507.29 | -3.8% | Jun 17, 2026 |
| Wolfe Research | Chris Caso | $450 | $511.57 | -27.9% | Jun 15, 2026 |
| Mizuho Securities | Analyst unavailable | $615 | $516.1 | -1.4% | Jun 1, 2026 |
| Barclays | Tom O'Malley | $665 | $516.1 | +6.6% | Jun 1, 2026 |
| Evercore ISI | Analyst unavailable | $579 | $420.99 | -7.2% | May 19, 2026 |
| Melius Research | Analyst unavailable | $540 | $418.15 | -13.4% | May 18, 2026 |
| Daiwa | Analyst unavailable | $500 | $448.29 | -19.8% | May 13, 2026 |
| Mizuho Securities | Analyst unavailable | $515 | $458.79 | -17.4% | May 12, 2026 |
| Susquehanna | Christopher Rolland | $450 | $408.3 | -27.9% | May 6, 2026 |
| Truist Financial | Analyst unavailable | $478 | $408.41 | -23.4% | May 6, 2026 |
| RBC Capital | Analyst unavailable | $400 | $415.21 | -35.9% | May 6, 2026 |
| Seaport Global | Jay Goldberg | $430 | $355.26 | -31.1% | May 6, 2026 |
| KeyBanc | Analyst unavailable | $530 | $355.26 | -15.0% | May 6, 2026 |
| Jefferies | Analyst unavailable | $415 | $355.26 | -33.5% | May 6, 2026 |
| Morgan Stanley | Analyst unavailable | $410 | $355.26 | -34.3% | May 6, 2026 |
| Cantor Fitzgerald | Analyst unavailable | $500 | $355.26 | -19.8% | May 6, 2026 |
| Barclays | Tom O'Malley | $500 | $355.26 | -19.8% | May 6, 2026 |
| Bernstein | Analyst unavailable | $525 | $355.26 | -15.8% | May 6, 2026 |
| Goldman Sachs | Analyst unavailable | $450 | $355.26 | -27.9% | May 6, 2026 |
| Roth Capital | Analyst unavailable | $500 | $355.26 | -19.8% | May 6, 2026 |
| HSBC | Analyst unavailable | $340 | $360.54 | -45.5% | May 4, 2026 |
| Susquehanna | Christopher Rolland | $375 | $323.21 | -39.9% | Apr 29, 2026 |
| Northland Securities | Market Perform | $260 | $347.8 | -58.3% | Apr 27, 2026 |
| D.A. Davidson | Analyst unavailable | $375 | $305.33 | -39.9% | Apr 24, 2026 |
| Stifel Nicolaus | Analyst unavailable | $320 | $278.39 | -48.7% | Apr 20, 2026 |
| Bernstein | Analyst unavailable | $265 | $258.12 | -57.5% | Apr 16, 2026 |
| KeyBanc | Analyst unavailable | $330 | $213.78 | -47.1% | Feb 24, 2026 |
| Evercore ISI | Analyst unavailable | $358 | $214.48 | -42.6% | Feb 24, 2026 |
| D.A. Davidson | Gil Luria | $220 | $205.94 | -64.7% | Feb 12, 2026 |
| Truist Financial | Analyst unavailable | $283 | $205.9 | -54.6% | Feb 4, 2026 |
| UBS | Analyst unavailable | $310 | $205.86 | -50.3% | Feb 4, 2026 |
| Morgan Stanley | Analyst unavailable | $255 | $242.11 | -59.1% | Feb 4, 2026 |
| Bernstein | Analyst unavailable | $235 | $242.11 | -62.3% | Feb 4, 2026 |
| UBS | Analyst unavailable | $330 | $250.81 | -47.1% | Jan 26, 2026 |
| Piper Sandler | Analyst unavailable | $300 | $259.68 | -51.9% | Jan 26, 2026 |
| Bernstein | Stacy Rasgon | $225 | $247.96 | -63.9% | Jan 21, 2026 |
| RBC Capital | Analyst unavailable | $230 | $223.6 | -63.1% | Jan 14, 2026 |
| Truist Financial | William Stein | $277 | $201.06 | -55.6% | Dec 19, 2025 |
| Cantor Fitzgerald | Analyst unavailable | $300 | $207.74 | -51.9% | Dec 16, 2025 |
| Raymond James | Analyst unavailable | $377 | $206.02 | -39.6% | Nov 20, 2025 |
| Mizuho Securities | Analyst unavailable | $285 | $237.52 | -54.3% | Nov 12, 2025 |
| Cantor Fitzgerald | Analyst unavailable | $350 | $237.52 | -43.9% | Nov 12, 2025 |
| Wells Fargo | Analyst unavailable | $345 | $237.52 | -44.7% | Nov 12, 2025 |
| Bernstein | Stacy Rasgon | $200 | $237.52 | -67.9% | Nov 12, 2025 |
| Melius Research | Ben Reitzers | $380 | $237.52 | -39.1% | Nov 12, 2025 |
| Truist Financial | Analyst unavailable | $279 | $250.33 | -55.3% | Nov 5, 2025 |
| Evercore ISI | Mark Lipacis | $270 | $252.13 | -56.7% | Nov 5, 2025 |
| Rosenblatt Securities | Kevin Cassidy | $300 | $250.33 | -51.9% | Nov 5, 2025 |
| Wedbush | Matt Bryson | $290 | $250.05 | -53.5% | Nov 5, 2025 |
| Morgan Stanley | Analyst unavailable | $260 | $250.05 | -58.3% | Nov 5, 2025 |
| UBS | Timothy Acuri | $300 | $250.05 | -51.9% | Nov 5, 2025 |
| Piper Sandler | Harsh Kumar | $280 | $250.05 | -55.1% | Nov 5, 2025 |
| Loop Capital Markets | Gary Mobley | $290 | $250.05 | -53.5% | Nov 5, 2025 |
| Robert W. Baird | Tristan Gerra | $300 | $250.05 | -51.9% | Nov 5, 2025 |
| Stifel Nicolaus | Ruben Roy | $280 | $250.05 | -55.1% | Nov 5, 2025 |
| Susquehanna | Christopher Rolland | $300 | $260.6 | -51.9% | Oct 31, 2025 |
| Wedbush | Matt Bryson | $270 | $218.09 | -56.7% | Oct 15, 2025 |
| HSBC | Frank Lee | $310 | $218.09 | -50.3% | Oct 15, 2025 |
| Deutsche Bank | Ross Seymore | $230 | $218.01 | -63.1% | Oct 14, 2025 |
| Deutsche Bank | Analyst unavailable | $235 | $216.42 | -62.3% | Oct 14, 2025 |
| Wolfe Research | Analyst unavailable | $300 | $216.42 | -51.9% | Oct 14, 2025 |
| Mizuho Securities | Analyst unavailable | $275 | $214.76 | -55.9% | Oct 13, 2025 |
| KGI Securities | Analyst unavailable | $260 | $214.76 | -58.3% | Oct 13, 2025 |
| Piper Sandler | Harsh Kumar | $240 | $211.25 | -61.5% | Oct 7, 2025 |
| Truist Financial | Analyst unavailable | $273 | $203.71 | -56.2% | Oct 7, 2025 |
| Evercore ISI | Analyst unavailable | $240 | $203.71 | -61.5% | Oct 7, 2025 |
| Morgan Stanley | Joseph Moore | $246 | $203.71 | -60.6% | Oct 7, 2025 |
| UBS | Timothy Arcuri | $265 | $203.71 | -57.5% | Oct 7, 2025 |
| Wells Fargo | Aaron Rakers | $275 | $203.71 | -55.9% | Oct 7, 2025 |
| Jefferies | Analyst unavailable | $300 | $203.71 | -51.9% | Oct 6, 2025 |
| Stifel Nicolaus | Analyst unavailable | $240 | $203.71 | -61.5% | Oct 6, 2025 |
| Melius Research | Analyst unavailable | $300 | $203.71 | -51.9% | Oct 6, 2025 |
| Roth Capital | Suji Desilva | $250 | $208.34 | -59.9% | Oct 6, 2025 |
| Barclays | Tom O'Malley | $300 | $208.34 | -51.9% | Oct 6, 2025 |
| Truist Financial | William Stein | $213 | $168.7 | -65.9% | Aug 26, 2025 |
| Deutsche Bank | Ross Seymore | $200 | $163.12 | -67.9% | Aug 6, 2025 |
| Morgan Stanley | Analyst unavailable | $185 | $179.51 | -70.3% | Jul 30, 2025 |
| HSBC | Frank Lee | $200 | $144.12 | -67.9% | Jul 10, 2025 |
| Roth Capital | Suji Desilva | $150 | $116.16 | -76.0% | Jun 13, 2025 |
| Evercore ISI | Mark Lipacis | $144 | $116.16 | -76.9% | Jun 13, 2025 |
| Barclays | Tom O'Malley | $130 | $117.17 | -79.2% | May 16, 2025 |
| UBS | Timothy Arcuri | $150 | $98.55 | -76.0% | May 7, 2025 |
| Melius Research | Ben Reitzes | $110 | $98.55 | -82.4% | May 7, 2025 |
| Stifel Nicolaus | Ruben Roy | $132 | $96.39 | -78.8% | Apr 28, 2025 |
| Loop Capital Markets | Vivek Arya | $160 | $88.29 | -74.3% | Apr 16, 2025 |
| Argus Research | Analyst unavailable | $160 | $110.16 | -74.3% | Feb 6, 2025 |
| Truist Financial | Analyst unavailable | $130 | $112.01 | -79.2% | Feb 5, 2025 |
| Morgan Stanley | Analyst unavailable | $137 | $112.01 | -78.0% | Feb 5, 2025 |
| KeyBanc | Analyst unavailable | $140 | $112.01 | -77.6% | Feb 5, 2025 |
| UBS | Analyst unavailable | $175 | $112.01 | -71.9% | Feb 5, 2025 |
| Roth Capital | Suji Desilva | $140 | $119.5 | -77.6% | Feb 5, 2025 |
| Morgan Stanley | Joseph Moore | $147 | $119.5 | -76.4% | Feb 4, 2025 |
| Susquehanna | Analyst unavailable | $165 | $117.35 | -73.5% | Jan 29, 2025 |
| Melius Research | Analyst unavailable | $129 | $114.17 | -79.3% | Jan 28, 2025 |
| Wedbush | Analyst unavailable | $150 | $115.01 | -76.0% | Jan 27, 2025 |
| Loop Capital Markets | Analyst unavailable | $175 | $117.32 | -71.9% | Jan 13, 2025 |
| Goldman Sachs | Toshiya Hari | $129 | $116.04 | -79.3% | Jan 10, 2025 |
| Piper Sandler | Harsh Kumar | $180 | $152.54 | -71.1% | Oct 30, 2024 |
| Robert W. Baird | Tristan Gerra | $175 | $166.25 | -71.9% | Oct 30, 2024 |
| Deutsche Bank | Ross Seymore | $150 | $166.25 | -76.0% | Oct 30, 2024 |
| Evercore ISI | Mark Lipacis | $198 | $166.25 | -68.3% | Oct 30, 2024 |
| Citigroup | Christopher Danely | $200 | $166.25 | -67.9% | Oct 30, 2024 |
| Barclays | Tom O'Malley | $170 | $166.25 | -72.7% | Oct 30, 2024 |
| Roth Capital | Suji Desilva | $200 | $163.41 | -67.9% | Oct 11, 2024 |
| KeyBanc | Justin Vinh | $220 | $167.01 | -64.7% | Oct 11, 2024 |
| Piper Sandler | Harsh Kumar | $200 | $166.81 | -67.9% | Oct 11, 2024 |
| Northland Securities | Gus Richard | $175 | $167.12 | -71.9% | Oct 11, 2024 |
| Citigroup | Christopher Danely | $210 | $164.18 | -66.3% | Oct 11, 2024 |
| Bank of America Securities | Vivek Arya | $180 | $144.67 | -71.1% | Jul 31, 2024 |
| Morgan Stanley | Joseph Moore | $178 | $138.44 | -71.5% | Jul 31, 2024 |
| Truist Financial | William Stein | $156 | $138.44 | -75.0% | Jul 31, 2024 |
| Barclays | Tom O'Malley | $180 | $139.99 | -71.1% | Jul 29, 2024 |
| Wells Fargo | Aaron Rakers | $205 | $183.96 | -67.1% | Jul 11, 2024 |
| Stifel Nicolaus | Ruben Roy | $200 | $158.4 | -67.9% | Jun 18, 2024 |
| Susquehanna | Christopher Rolland | $200 | $167.87 | -67.9% | Jun 10, 2024 |
| CFRA | Angelo Zino | $200 | $162.48 | -67.9% | Jun 3, 2024 |
| Jefferies | Blayne Curtis | $190 | $151.92 | -69.5% | May 13, 2024 |
| Roth Capital | Suji Desilva | $180 | $158.38 | -71.1% | May 1, 2024 |
| Piper Sandler | Harsh Kumar | $175 | $147.39 | -71.9% | May 1, 2024 |
| Truist Financial | William Stein | $162 | $147.88 | -74.0% | May 1, 2024 |
| Mizuho Securities | Vijay Rakesh | $215 | $147.22 | -65.5% | May 1, 2024 |
| HSBC | Frank Lee | $220 | $158.38 | -64.7% | May 1, 2024 |
| Rosenblatt Securities | Hans Mosesmann | $250 | $159.96 | -59.9% | Apr 29, 2024 |
| Susquehanna | Christopher Rolland | $185 | $159.58 | -70.3% | Apr 29, 2024 |
| HSBC | Frank Lee | $225 | $160.32 | -63.9% | Apr 15, 2024 |
| Evercore ISI | Mark Lipacis | $200 | $160.32 | -67.9% | Apr 15, 2024 |
| Piper Sandler | Harsh Kumar | $195 | $165.83 | -68.7% | Apr 5, 2024 |
| KeyBanc | John Vinh | $270 | $192.39 | -56.7% | Mar 15, 2024 |
| Northland Securities | Gus Richard | $195 | $167.36 | -68.7% | Jan 31, 2024 |
| Susquehanna | Christopher Rolland | $210 | $176.39 | -66.3% | Jan 29, 2024 |
| UBS | Timothy Arcuri | $220 | $179.15 | -64.7% | Jan 25, 2024 |
| New Street | Pierre Ferragu | $215 | $168.42 | -65.5% | Jan 23, 2024 |
| Mizuho Securities | Vijay Rakesh | $162 | $168.42 | -74.0% | Jan 23, 2024 |
| Melius Research | Ben Reitzers | $188 | $146.18 | -69.9% | Jan 8, 2024 |
| Loop Capital Markets | John Vinh | $170 | $135.32 | -72.7% | Jan 4, 2024 |
| Mizuho Securities | Vijay Rakesh | $130 | $128.37 | -79.2% | Dec 7, 2023 |
| Raymond James | Srini Pajjuri | $125 | $108.04 | -80.0% | Nov 1, 2023 |
| BMO Capital | Ambrish Srivastava | $140 | $95.97 | -77.6% | Oct 30, 2023 |
| Morgan Stanley | Joseph Moore | $138 | $110.15 | -77.9% | Aug 2, 2023 |
| Raymond James | Srini Pajjuri | $145 | $126.51 | -76.8% | Jun 14, 2023 |
| Wedbush | Matt Bryson | $95 | $81.86 | -84.8% | May 3, 2023 |
| Morgan Stanley | Joseph Moore | $102 | $88.92 | -83.6% | May 2, 2023 |
| Citigroup | Analyst unavailable | $76 | $84.64 | -87.8% | Feb 2, 2023 |
| Morgan Stanley | Joseph Moore | $87 | $81.71 | -86.1% | Feb 1, 2023 |
| Barclays | Blayne Curtis | $85 | $75.15 | -86.4% | Jan 31, 2023 |
| Oppenheimer | Rick Schafer | $112.5 | $36.19 | -82.0% | Nov 11, 2022 |
| UBS | Timothy Arcuri | $75 | $59.66 | -88.0% | Nov 2, 2022 |
| Raymond James | Melissa Fairbanks | $80 | $58.63 | -87.2% | Nov 2, 2022 |
| KeyBanc | John Vinh | $85 | $58.63 | -86.4% | Nov 2, 2022 |
| Mizuho Securities | Vijay Rakesh | $95 | $59.66 | -84.8% | Nov 1, 2022 |
| Morgan Stanley | Joseph Moore | $77 | $60.06 | -87.7% | Oct 31, 2022 |
| Loop Capital Markets | John Vinh | $100 | $61.87 | -84.0% | Oct 7, 2022 |
| Morgan Stanley | Joseph Moore | $95 | $62.95 | -84.8% | Oct 7, 2022 |
| J.P. Morgan | Harlan Sur | $80 | $58.44 | -87.2% | Oct 7, 2022 |
| Truist Financial | William Stein | $70 | $58.44 | -88.8% | Oct 7, 2022 |
| KeyBanc | John Vinh | $100 | $58.44 | -84.0% | Oct 7, 2022 |
| Robert W. Baird | Tristan Gerra | $65 | $58.44 | -89.6% | Oct 7, 2022 |
| KeyBanc | John Vinh | $100 | $67.85 | -84.0% | Oct 7, 2022 |
| Piper Sandler | Harsh Kumar | $90 | $67.85 | -85.6% | Oct 6, 2022 |
| Piper Sandler | Harsh Kumar | $90 | $67.85 | -85.6% | Oct 6, 2022 |
| Wells Fargo | Aaron Rakers | $85 | $67.94 | -86.4% | Oct 5, 2022 |
| Goldman Sachs | Toshiya Hari | $88 | $67.9 | -85.9% | Oct 4, 2022 |
| Mizuho Securities | Vijay Rakesh Rakesh | $62.5 | $33.98 | -90.0% | Sep 24, 2022 |
| Mizuho Securities | Vijay Rakesh | $140 | $100.83 | -77.6% | Aug 15, 2022 |
| Goldman Sachs | Analyst unavailable | $112 | $99.45 | -82.0% | Aug 4, 2022 |
| Northland Securities | Analyst unavailable | $105 | $95.95 | -83.2% | Aug 3, 2022 |
| J.P. Morgan | Analyst unavailable | $120 | $99.29 | -80.8% | Aug 3, 2022 |
| Deutsche Bank | Analyst unavailable | $95 | $99.29 | -84.8% | Aug 3, 2022 |
| UBS | Analyst unavailable | $120 | $99.29 | -80.8% | Aug 3, 2022 |
| Raymond James | Analyst unavailable | $130 | $99.29 | -79.2% | Aug 3, 2022 |
| Citigroup | Analyst unavailable | $96 | $99.29 | -84.6% | Aug 3, 2022 |
| Deutsche Bank | Ross Seymore | $85 | $94.47 | -86.4% | Jul 30, 2022 |
| BMO Capital | Ambrish Srivastava | $115 | $87.54 | -81.6% | Jul 26, 2022 |
| Wells Fargo | Aaron Rakers | $130 | $85.85 | -79.2% | Jul 19, 2022 |
| Susquehanna | Christopher Rolland | $120 | $78.6 | -80.8% | Jul 15, 2022 |
| KeyBanc | John Vinh | $130 | $77.24 | -79.2% | Jul 14, 2022 |
| Cowen & Co. | Analyst unavailable | $120 | $75.81 | -80.8% | Jul 12, 2022 |
| Morgan Stanley | Joseph Moore | $103 | $85.84 | -83.5% | Jun 22, 2022 |
| Goldman Sachs | Toshiya Hari | $133 | $94.82 | -78.7% | Jun 13, 2022 |
| Loop Capital Markets | John Vinh | $150 | $94.72 | -76.0% | Jun 10, 2022 |
| Robert W. Baird | Tristan Gerra | $100 | $94.82 | -84.0% | Jun 10, 2022 |
| KeyBanc | John Vinh | $150 | $94.82 | -76.0% | Jun 10, 2022 |
| Rosenblatt Securities | Hans Mosesmann | $100 | $49.4 | -84.0% | Jun 9, 2022 |
| Piper Sandler | Harsh Kumar | $140 | $105.28 | -77.6% | Jun 7, 2022 |
| Stifel Nicolaus | Patrick Ho | $98.5 | $52.68 | -84.2% | Jun 6, 2022 |
| Stifel Nicolaus | Patrick Ho | $98.5 | $52.83 | -84.2% | Jun 6, 2022 |
| Bank of America Securities | Vivek Arya | $160 | $106.3 | -74.3% | Jun 3, 2022 |
| Piper Sandler | Harsh Kumar | $140 | $102.47 | -77.6% | May 17, 2022 |
| Piper Sandler | Harsh Kumar | $100.06 | $102.47 | -84.0% | May 17, 2022 |
| Piper Sandler | Harsh Kumar | $98 | $98.86 | -84.3% | May 17, 2022 |
| KeyBanc | John Vinh | $150 | $93.87 | -76.0% | May 5, 2022 |
| Mizuho Securities | Analyst unavailable | $145 | $91.92 | -76.8% | May 4, 2022 |
| Jefferies | Mark Lipacis | $147 | $91.13 | -76.4% | May 4, 2022 |
| Rosenblatt Securities | Hans Mosesmann | $100 | $45.57 | -84.0% | May 4, 2022 |
| Deutsche Bank | Ross Seymore | $115 | $88.14 | -81.6% | Apr 25, 2022 |
| Wells Fargo | Analyst unavailable | $140 | $90.36 | -77.6% | Apr 22, 2022 |
| Susquehanna | Christopher Rolland | $160 | $93.89 | -74.3% | Apr 18, 2022 |
| Truist Financial | William Stein | $111 | $101 | -82.2% | Apr 10, 2022 |
| Deutsche Bank | Ross Seymore | $125 | $101 | -80.0% | Apr 9, 2022 |
| Barclays | Blayne Curtis | $115 | $108.19 | -81.6% | Apr 3, 2022 |
| Bernstein | Stacy Rasgon | $150 | $115.65 | -76.0% | Feb 22, 2022 |
| Cowen & Co. | Matt Ramsay | $145 | $121.47 | -76.8% | Feb 15, 2022 |
| Mizuho Securities | Vijay Rakesh | $160 | $114.27 | -74.3% | Feb 13, 2022 |
| Wells Fargo | Aaron Rakers | $180 | $113.18 | -71.1% | Feb 11, 2022 |
| Daiwa | Louis Miscioscia | $150 | $132.85 | -76.0% | Feb 9, 2022 |
| Jefferies | Mark Lipacis | $155 | $123.6 | -75.2% | Feb 6, 2022 |
| Raymond James | Chris Caso | $160 | $122.76 | -74.3% | Feb 2, 2022 |
| Craig-Hallum | Christian Schwab | $160 | $122.76 | -74.3% | Feb 2, 2022 |
| BMO Capital | Ambrish Srivastava | $130 | $122.76 | -79.2% | Feb 2, 2022 |
| Robert W. Baird | Tristan Gerra | $125 | $116.78 | -80.0% | Feb 1, 2022 |
| Piper Sandler | Harsh Kumar | $130 | $121.89 | -79.2% | Jan 20, 2022 |
| KeyBanc | John Vinh | $155 | $136.88 | -75.2% | Jan 17, 2022 |
| Wedbush | Matt Bryson | $165 | $148.92 | -73.5% | Nov 9, 2021 |
| Northland Securities | Gus Richard | $120 | $125.23 | -80.8% | Nov 1, 2021 |
| UBS | Timothy Arcuri | $115 | $122.28 | -81.6% | Oct 27, 2021 |
| Benchmark Co. | David Williams | $145 | $122.28 | -76.8% | Oct 27, 2021 |
| New Street | Pierre Ferragu | $70 | $97.93 | -88.8% | Jul 28, 2021 |
| Argus Research | Jim Kelleher | $120 | $97.93 | -80.8% | Jul 28, 2021 |
Track every rating change on AMD the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationAdvanced Micro Devices, Inc. (AMD), established in 1969 and headquartered in Santa Clara, California, operates as a global leader in the semiconductor industry. The company organizes its extensive operations into two primary segments: Computing and Graphics, and Enterprise, Embedded and Semi-Custom. In its Computing and Graphics division, AMD develops a range of products including x86 microprocessors (often as accelerated processing units), chipsets, and various graphics processing units (GPUs), encompassing discrete, integrated, data center, and professional variants, alongside providing development services. The Enterprise, Embedded and Semi-Custom segment focuses on server and embedded processors, bespoke System-on-Chip (SoC) products, and foundational technology for popular game consoles, also offering associated development support.…
Historical context
All AMD earningsTechnology peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| ADBE Adobe Inc. | FY2026 Q3 · Calendar Q3 2026 | +0.8% | +1.4% | Adobe raises FY26 outlook as AI strategy broadens |
| ORCL Oracle Corporation | FY2027 Q1 · Calendar Q3 2026 | +10.3% | -1.7% | Oracle raises FY27 outlook as AI demand accelerates cloud growth |
| SAIL SailPoint, Inc. | FY2027 Q2 · Calendar Q3 2026 | +13.8% | -1.2% | SailPoint pairs 25% ARR growth with accelerating AI-driven adoption |
| CIEN Ciena Corporation | FY2026 Q3 · Calendar Q3 2026 | +22.0% | -10.4% | Ciena raises outlook as AI networking demand lifts backlog |
| DOCU DocuSign, Inc. | FY2027 Q2 · Calendar Q3 2026 | +6.4% | +3.7% | DocuSign Q2 FY27: IAM momentum supports a raised outlook |
| IOT Samsara Inc. | FY2027 Q2 · Calendar Q3 2026 | +25.0% | +3.7% | Samsara: AI adoption expands as FY27 guidance holds |
Latest beats and misses
Who reports nextBeat on EPS
- FPSFY2026 Q4 · September 15, 2026+4.3% EPS+9.5% move
- TCOMFY2026 Q2 · September 15, 2026+22.3% EPS+3.0% move
- KRFY2026 Q2 · September 11, 2026+2.8% EPS+2.7% move
- ADBEFY2026 Q3 · September 10, 2026+0.8% EPS+1.4% move
- ORCLFY2027 Q1 · September 10, 2026+10.3% EPS-1.7% move
- CASYFY2027 Q1 · September 8, 2026+8.7% EPS-14.2% move
Get the AMD recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-08-05T14:14:52.155930+00:00
- FN2 earnings calendar · 2026-09-09T01:23:14.388487+00:00
- Polygon adjusted daily market bars · 2026-09-22T20:30:56.837893+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-09-22T20:30:56.834941+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-09-22. For educational purposes only; not investment advice.